The latest trading session saw Moderna (MRNA) ending at $53.80, denoting a -0.55% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily loss of 0.18%. Elsewhere, ...

Winnipeggers are being encouraged to get vaccinated against influenza and COVID-19 as respiratory virus infections begin to ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

TD Cowen analyst Tyler Van Buren has maintained their neutral stance on MRNA stock, giving a Hold rating on October 17. Tyler Van ...

A new study by researchers at Zhejiang University has highlighted the disproportionate health challenges faced by sexual and ...

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?

TD Cowen维持对Moderna股票(NASDAQ: MRNA)的"持有"评级，目标价保持在60.00美元不变。 该公司在生物科技板块第三季度财报预览前发布了这一更新，并对Moderna的财务模型进行了调整。

The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...

In recent years, the biotech industry has seen a lot of exciting changes, and much of that is thanks to one company: Moderna.

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do ...

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.